Senior Director Safety Surveillance Semaglutide, Insulin and CVD @ (September 2024 - December 2025)
Director, Head of Clinical Reporting @ (March 2024 - September 2024)
Associate Director, Head of Medical Writing @ (November 2021 - March 2024)
Associate Director, Clinical Drug Safety @ (April 2020 - November 2021)
Drug Safety Advisor @ (October 2018 - April 2020)
Senior and Principal Medical Writer @ (August 2014 - October 2018)
Senior Manager, Medical Affairs @ (December 2011 - July 2014)
Medical Manager @ Ferrosan A/S (June 2009 - November 2011)
Head of Scientific Affairs @ Ferrosan A/S (June 2006 - June 2009)
Medical Advisor @ Ferrosan A/S (October 2003 - June 2006)
Scientific Advisor @ Danish Nutrition Council (January 2003 - October 2003)
Brian Stage Education
Københavns Universitet - University of Copenhagen
M.Sc (Human Nutrition)
2000-2003
Københavns Universitet - University of Copenhagen
Bachelor's degree (Medicine)
1997-2000
Teknisk skole slagelse
High School
1994-1996
Brian Stage Skills
Safety Surveillance
Clinical Research
Project Management
Product Development
Due Diligence
Clinical Trials
Pharmaceutical Industry
Regulatory Affairs
Medical Writing
Stakeholder Management
Standard Operating Procedure Sop
Regulatory
GCP
Leader
Scientific Communications
KOL Identification
Regulatory Submissions
Medical Affairs
Advisory Boards
Pharmacovigilance
Standard Operating Procedure
Brian Stage Summary
Brian Stage, based in Denmark, is currently a Sr. Director, Post-Marketing Safety Surveillance at Novo Nordisk. Brian Stage brings experience from previous roles at Novo Nordisk, ALK and Y-mAbs Therapeutics, Inc.. Brian Stage holds a 2000 - 2003 M.Sc in Human Nutrition @ Københavns Universitet - University of Copenhagen. With a robust skill set that includes Safety Surveillance, Clinical Research, Project Management, Product Development, Due Diligence and more. Brian Stage has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Brian Stage?
Find contact details for 700 million professionals.